This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
October 15, 2018
Nomination Committee appointed in respect of AGM 2019 in Oncopeptides
October 15, 2018
Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer
October 12, 2018
GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology
October 12, 2018
Oncopeptides to present at the Jefferies London Healthcare Conference on November 14th
October 12, 2018
Nordic Nanovector Presentations at the Annual Congress of the European Association of Nuclear Medicine (EANM)
October 11, 2018
Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018
October 09, 2018
Rights issue in Vicore oversubscribed by 33 percent – The company receives SEK 82.4M
October 08, 2018
Altimmune Announces $25 million Registered Direct Offering
October 08, 2018
BONESUPPORT to Showcase CERAMENT® BONE VOID FILLER at Two Upcoming US Orthopedic Conferences
October 08, 2018
Orexo appoints Nomination Committee and publishes financial calendar 2018/2019